Загрузка...
miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy
SIMPLE SUMMARY: Cancer onset and progression are promoted by high deregulation of the immune system. Recently, major advances in molecular and clinical cancer immunology have been achieved, offering new agents for the treatment of common tumors, often with astonishing benefits in terms of prolonged...
Сохранить в:
| Опубликовано в: : | Cancers (Basel) |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8036682/ https://ncbi.nlm.nih.gov/pubmed/33808190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13071587 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|